Clinical Trial Details

EORTC-26062-22061

Back to Clinical Trials Database

A randomized phase III study of Temozolomide and short-course radiation versus short-course radiation alone in the treatment of newly diagnosed glioblastoma multiforme in elderly patients

Study documentation Publications

Trial Status All trial activities ended
Dates Date of activation: 31-Aug-2009
Date Step1 close: 19-Sep-2013
Data management at EORTC No
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 200 - All Groups: 560
Treatment Temozolomide
Study Staff
Type of cancer
Participating groups EORTC Brain Tumor Group
EORTC Radiation Oncology Group
NCIC Clinical Trial Group
Protocol summary http://clinicaltrials.gov/ct/show/NCT00482677
NCT number NCT00482677
EudraCT 2008-001949-26